医学
生长激素
内科学
生长速度
激素疗法
儿科
激素
癌症
乳腺癌
作者
Banu Küçükemre Aydın,Zehra Aycan,Zeynep Şıklar,Merih Berberoğlu,Gönül Öçal,Semra Çeti̇nkaya,Veysel Nijat Baş,Havva Nur Peltek Kendırcı,Ergün Çetinkaya,Şükran Darcan,Damla Gökşen,Olcay Evliyaoğlu,Mine Şükür,Firdevs Baş,Feyza Darendelıler
摘要
ABSTRACT
Objective
To evaluate the adherence to growth hormone (GH) therapy and identify the influencing factors and outcomes in children. Methods
A total of 217 GH-naïve patients in 6 pediatric endocrinology clinics were enrolled in the study. Structured questionnaires were filled out and patients were evaluated at the initiation and 3rd, 6th, and 12th months of therapy. Patients were categorized into 4 adherence segments based on percentage of doses omitted at each evaluation period, classified as excellent if 0%, good if 5%, fair if 5 to 10%, and poor if >10%. Results:
There was a decrement in adherence to GH therapy during the study period (P = .006). Patients who showed excellent and good adherence to therapy had better growth velocity and growth velocity standard deviation scores (SDSs) (P = .014 and P = .015, respectively). A negative correlation between growth velocity SDS and number of missed injections was also observed (r = −.412; P = .007). A positive correlation between delta insulin-like growth factor-1 (IGF-1) SDS and growth velocity was demonstrated (r = .239; P = .042). IGF-1 levels were significantly higher in patients who showed excellent and good adherence to therapy (P = .01). Adherence was better in boys than in girls (P = .035), but adherence rates were not associated with age, cause of GH treatment, socioeconomic status, person who administered the injections, type of injection device, or GH product. Conclusion
Poor adherence to GH therapy was common in our group of patients and was one of the factors underlying suboptimal growth during therapy. Before considering other problems that can affect growth, clinicians should confirm good adherence to therapy. (Endocr Pract. 2014;20:46-51)
科研通智能强力驱动
Strongly Powered by AbleSci AI